Showing 581–600 of 651 signals
Trade press·pharmatimes.com·Aug 13, 2026·Trial readout·High materiality
CompaniesKupandoAssetsKUP101Diseasesadvanced solid tumours
Trade press·pharmatimes.com·Aug 17, 2026·Commercial·High materiality
CompaniesNovo NordiskAmazon Web Services (AWS)
Trade press·pharmatimes.com·Aug 17, 2026·Trial readout·Medium materiality
CompaniesCancer Research UKKisoJi Biotechnology Inc.AssetsKJ-103DiseasesTROP2-positive cancers
Trade press·pharmaceutical-technology.com·Aug 14, 2026·M&A·High materiality
CompaniesKhartis TherapeuticsGileadPfizerLilly Asia VenturesDiseasesautoimmune diseasethyroid eye disease
Trade press·pharmaceutical-technology.com·Aug 17, 2026·Approval·High materiality
CompaniesPhanes TherapeuticsMerck & Co.AssetsspevatamigDiseasesadvanced and metastatic biliary tract carcinoma
Trade press·pharmaceutical-technology.com·Aug 17, 2026·Approval·High materiality
CompaniesPfizerValnevaAssetsPF-07307405DiseasesLyme disease
Trade press·pharmaceutical-technology.com·Aug 17, 2026·Approval·High materiality
CompaniesLantheus HoldingsAssetsTauklarifyDiseasesAlzheimer's disease
Trade press·pharmaceutical-technology.com·Aug 17, 2026·Commercial·High materiality
CompaniesGSKBoehringer IngelheimTakeda
Trade press·pharmaceutical-technology.com·Aug 18, 2026·M&A·High materiality
CompaniesFulcrum TherapeuticsSlate MedicinesAssetsSLTE-1009SLTE-2100Diseasesmigraineheadache disorders
Trade press·pharmaceutical-technology.com·Aug 18, 2026·Approval·High materiality
CompaniesFaeth TherapeuticsAssetsPIKTORpaclitaxelDiseasesadvanced or recurrent endometrial cancer
Trade press·pharmaceutical-technology.com·Aug 18, 2026·M&A·High materiality
CompaniesLEO PharmaTanabe PharmaAssetsdersimelagonDiseaseserythropoietic protoporphyriaX-linked protoporphyria
Trade press·pharmaceutical-technology.com·Aug 18, 2026·Commercial·Low materiality
CompaniesNICEDiseasesheart failure
Company disclosure·news.abbvie.com·Aug 18, 2026·Other·Low materiality
CompaniesAbbVieDiseasesatopic dermatitispsoriasisCrohn's diseaseulcerative colitisjuvenile idiopathic arthritis
Journal·doi.org·Aug 3, 2026·not yet scored
Journal·doi.org·Aug 3, 2026·not yet scored
Journal·doi.org·Aug 3, 2026·not yet scored
Journal·doi.org·Aug 3, 2026·not yet scored
Journal·doi.org·Aug 3, 2026·not yet scored
Journal·doi.org·Aug 3, 2026·not yet scored
Journal·doi.org·Aug 3, 2026·not yet scored